---
title: "SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 43.06 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286402311.md"
datetime: "2026-05-14T10:52:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286402311.md)
  - [en](https://longbridge.com/en/news/286402311.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286402311.md)
---

# SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 43.06 M

Revenue: As of FY2026 Q1, the actual value is USD 43.06 M.

EPS: As of FY2026 Q1, the actual value is USD 0.11.

EBIT: As of FY2026 Q1, the actual value is USD 17.71 M.

### Financial Performance Highlights (Three Months Ended March 31, 2026)

#### Operational Metrics

-   **Net Income Attributable to SBC Medical Group Holdings Incorporated**: $11,308,071, representing a 47% year-over-year decrease .
-   **Net Income Margin**: 26% for the first quarter of 2026, a year-over-year decrease of 19 percentage points from 45% in 2025 .
-   **Gross Profit**: $30,346,734, compared to $37,733,084 for the same period in 2025 .
-   **Selling, General and Administrative Expenses**: $12,626,719, compared to $13,531,010 for the same period in 2025 .
-   **Income from Operations**: $17,720,015, compared to $24,202,074 for the same period in 2025 .
-   **EBITDA**: $18,390,449, marking a 26% year-over-year decrease .
-   **EBITDA Margin**: 43% for the first quarter of 2026, a year-over-year decrease of 10 percentage points from 52% in 2025 .
-   **Return on Equity**: 18%, representing a 23 percentage point year-over-year decrease .

#### Cash Flow

-   **Net Cash Provided by Operating Activities**: $9,231,938, significantly up from $1,928,621 in the prior year period .
-   **Free Cash Flow**: Not explicitly provided or directly calculable from the given financial statements within the reference .

#### Balance Sheet Snapshot (as of March 31, 2026)

-   **Cash and Cash Equivalents**: $167,305,095, an increase from $163,773,838 as of December 31, 2025 .
-   **Total Liabilities**: $117,635,399, compared to $117,143,240 as of December 31, 2025 .
-   **Total Stockholders’ Equity**: $270,384,177, compared to $263,304,706 as of December 31, 2025 .

#### Unique Operational Metrics

-   **Number of Franchise Locations**: 284 as of March 31, 2026, an increase of 33 locations from March 31, 2025 .
-   **Number of Customers**: 6.76 million in the last twelve months ended March 31, 2026, a 10% year-over-year increase .
-   **Repeat Rate for Customers**: 72% for customers who visited franchisee’s clinics twice or more .

#### Outlook / Guidance

SBC Medical Group Holdings Incorporated plans to continue its multi-brand strategy in aesthetic dermatology and expand its non-aesthetic medical business, while also strengthening its operational foundation in overseas markets . The company will pursue opportunities in the longevity market and enhance services through AI, aiming to build a sustainable and continuously growing healthcare platform .

### Related Stocks

- [SBCWW.US](https://longbridge.com/en/quote/SBCWW.US.md)

## Related News & Research

- [SBC: 2Q 2026 saw 13% revenue growth and 335% net income surge, with strong global expansion plans](https://longbridge.com/en/news/295781152.md)
- [11:24 ETRemotePeople Completes 2026 SOC 2 Type II Audit Across Security, Availability, and Confidentiality](https://longbridge.com/en/news/295953241.md)
- [SOC: Ramping up offshore production with robust cash flow and optimized capital structure](https://longbridge.com/en/news/295454306.md)
- [REG - Soc EnergElectricaSA - Availability of Half-year Report and Webconference](https://longbridge.com/en/news/296112539.md)
- [REG - Soc EnergElectricaSA - H12026 Preliminary Key Operational Indicators](https://longbridge.com/en/news/295424368.md)